Navigation Links
Contemplating the effects of the “Morning After“ Pill

A recent study has shown that the ''morning after'' contraceptive pills work// by interfering with ovulation thereby preventing fertilization and not by preventing implantation of a fertilized egg.

Reproductive physiologists demonstrated the phenomenon in a controlled clinical trial published in the December 2004 . When the pills, also known as emergency contraception (EC) were given before ovulation, they were able to inhibit or postpone ovulation; pregnancy rates among those taking these pills were lower than among those taking a placebo. However, when EC was given subsequent to ovulation, evidenced by hormonal monitoring researchers say they found was no difference in pregnancy rates between the two groups and it was observed that the rate at which ovulation was impaired in their study was identical to the estimated efficacy of EC. Thus indicating that EC is does not work as an abortifacient.
'"/>




Page: 1

Related medicine news :

1. Medicos In Punjab, Haryana Contemplating Drastic Steps
2. Just spice it up!!!!! Anti bacterial effects of spices unraveled in the West
3. Protective effects of tomatoes in prostate cancer
4. Toxic effects common with AIDS treatments
5. Contraceptives have dual effects
6. Cooling decreases heart attack effects
7. Heart Drug has grave side effects
8. Ways to counter radiation effects with new molecule discovery
9. The effects of Curcumin: a natural pigment in turmeric explored for its anti-cancer properties
10. A treatment for lung cancer: similar to Vitamin A but with few side effects.
11. Re-evaluation of the soy protein’s effects to reduce cholestero
Post Your Comments:
(Date:12/2/2008)...ire/ -- In response to the commentary entitled "Co...ory Infections, and the Vitamin D Deficiency Epide...upplement experts, Nordic Naturals announced today... compromise to consumers and actually offer health...al Vitamin A. According to Karin Yien, MD, Nordic ...
(Date:12/2/2008)...ollect and disseminate pharmacy experience and kno.... (PRWEB) December 2, 2008 -- Pharmacy OneSource,...ive to focus public and industry attention on med...f SPEAK will occur during the American Society of ...ical Meeting, to be held December 7-11 in Orlando,...
(Date:12/2/2008)...ealth, a leading provider of onsite health service... Balance, the athletic products company, has selec...ge onsite health clinics and to provide health ser...e , Burlington, VT (PRWEB...rovider of onsite employee health services and tec...
(Date:12/2/2008)...t of Normal Gait Deviations and Treatment Options ...s of a three-day workshop to be held at La Rabida ... Chicago, IL (PRWEB) December 2, 200...atment Options for the Child with Cerebral Palsy w...d at La Rabida Children,s Hospital Dec. 5 through ...
Breaking Medicine News(10 mins):Health News:Nordic Naturals Offers Cod Liver Oil Solutions in Response to Recent Vitamin A and Vitamin D Controversy 2Health News:Pharmacy OneSource Launches SPEAK Initiative to Promote Medication Safety Awareness 2Health News:Marathon Health Joins Forces with New Balance for Employee Health - Associate Health Services Provided at Three Maine Locations 2Health News:Marathon Health Joins Forces with New Balance for Employee Health - Associate Health Services Provided at Three Maine Locations 3Health News:La Rabida Children's Hospital to Host Three-Day Course on Gait Treatment Options for Children with Cerebral Palsy 2
...tish Columbia medical association report it was an..., hip or knee operations should not be made to wai... released two reports which were commissioned by t...ations. Long waits result in further deterioration...
...orgia Institute of Technology have discovered a pr... in fatal-disease conditions //like tumour growth ...archers have found that the location of a hairpin-...d of the chromosome will determine the fate of the...
... tomatoes that contain edible vaccine could be use...amely HIV and hepatitis B//. Researchers have de...accines that could be grown and processed in poore... a very large need but no funds available to produ...
...s in a tight spot after a complaint recorded in th...or medical negligence in diagnosing an ovarian cys...ot been made public, communicated to the tribunal ...d been consulting him for 12 years, but had not po...
Other Medicine News:Health News:How to Hinder Gene Amplification? - Researchers Revealed 2
(Date:12/1/2008)...Prox1 gene is a two-way switch that, if turned off...ammed so that they lose their identity and become ...IS, Tenn., Dec. 1 Scie...ve discovered that a certain differentiated cell t...uires the constant expression of a gene called Pr...
(Date:12/1/2008)...ecember 1 Following a,R... to procure an MVA-based,third generation smallp...Canada, on behalf of the Canadian Department of Na...n Nordic for the delivery of IMVAMUNE(R). , ...) as part of the,country,s bio-preparedness progr...
(Date:12/1/2008)...wire-FirstCall/ -- Vical Incorporated (Nasdaq: V...n milestone payment from Merck & Co., Inc. bas...ical trial of an investigational plasmid DNA (pDNA...n Vical,s DNA gene delivery technology and encodes...TERT is the subject of separate license agreement....
(Date:11/28/2008)...vember 28 German biotech company,...alized HIV monitoring and,AIDS patient follow-up ... In,the year 2008, 2.5 million patient tests have...hly affordable "CyFlow" system, supporting already... Due to introduction of the,Partec innovation, th...
Breaking Medicine Technology:Reprogrammable Cell Type Depends on a Single Gene to Keep Its Identity 2Reprogrammable Cell Type Depends on a Single Gene to Keep Its Identity 3The Government of Canada Procures IMVAMUNE(R) Smallpox Vaccine for the Country's Biological Preparedness 2The Government of Canada Procures IMVAMUNE(R) Smallpox Vaccine for the Country's Biological Preparedness 3Vical Receives Milestone Payment from Merck & Co., Inc. Triggered by Planned Initiation of Investigational Cancer DNA Vaccine Trial 2German Innovation for HIV/AIDS Diagnostics has Been Used 2.5 Million Times in 2008 2Pediatric Researchers Find Possible Master Switch Gene in Juvenile Arthritis 2570 1Pediatric Researchers Find Possible Master Switch Gene in Juvenile Arthritis 2570 2Pediatric Researchers Find Possible Master Switch Gene in Juvenile Arthritis 2570 3Death Rates for HIV Patients Decrease Dramatically 23075 1Death Rates for HIV Patients Decrease Dramatically 23075 2Death Rates for HIV Patients Decrease Dramatically 23075 3Best treatment for MS may depend on disease subtype 23072 1Best treatment for MS may depend on disease subtype 23072 2Best treatment for MS may depend on disease subtype 23072 3The Parkinsons Disease Foundation awards 24950 000 in seed grants 3849 1The Parkinsons Disease Foundation awards 24950 000 in seed grants 3849 2The Parkinsons Disease Foundation awards 24950 000 in seed grants 3849 3
...S WIRE)--Mar 22, 2007 - Nutra Pharma,Corp. (OTCBB:...,drugs for HIV and Multiple Sclerosis has today an...harm, has received notification of,acceptance of i...n,Immunology special conference issue., The articl...y,for Multiple Sclerosis; a review of the literatu...
...aplatin Demonstrated Statistically,Significant Imp...BERLIN, March 22, 2007 /PRNewswire-FirstCall/ -- P...nced additional data from,the double-blind, random... SPARC trial (Satraplatin and Prednisone Against,R...e 22nd Annual,European Association of Urology Cong...
Other Medicine Technology:Nutra Pharma Announces Publication of Research on Treatment for,Multiple Sclerosis 2Nutra Pharma Announces Publication of Research on Treatment for,Multiple Sclerosis 3Additional Data From Satraplatin SPARC Phase 3 Trial Presented at,European Association of Urology Congress 2Additional Data From Satraplatin SPARC Phase 3 Trial Presented at,European Association of Urology Congress 3Additional Data From Satraplatin SPARC Phase 3 Trial Presented at,European Association of Urology Congress 4Additional Data From Satraplatin SPARC Phase 3 Trial Presented at,European Association of Urology Congress 5Additional Data From Satraplatin SPARC Phase 3 Trial Presented at,European Association of Urology Congress 6Additional Data From Satraplatin SPARC Phase 3 Trial Presented at,European Association of Urology Congress 7
Measles IgG ELISA test system is designed for the qualitative detection of IgG antibodies to Measles (Rubeola) virus in human serum, and is for in vitro diagnostic use.
Inquire
... Enzymelinked Immunosorbent Assays(ELISA) is inten...on of IgG antibody to Measles Rubeola) virus in hu...or the determination of immune status. Paired sera...rate seroconversion or a significant rise in antib...
The DSL-05-01-MEM Measles IgM Enzyme-Linked Immunosorbent Assay (ELISA) kit provides materials for the determination of IgM-class antibodies to Measles virus in human serum. This assay is intended fo
Medicine Products: